Raymond J. Hohl

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson et al. · British Journal of Cancer · 2000 · 939 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann et al. · Blood · 2001 · 445 citations · Full text

Medicine, Oncology, Pharmacology +9

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Alain Thibault, Dvorit Samid, A Tompkins et al. · PubMed · 1996 · 361 citations

Medicine, Oncology, Pharmacology +10

Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301

Antonius A. Miller, Daryl J. Murry, Kouros Owzar et al. · Journal of Clinical Oncology · 2009 · 207 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

Phase I and Pharmacokinetic Trial of Gemcitabine in Patients With Hepatic or Renal Dysfunction: Cancer and Leukemia Group B 9565

Alan P. Venook, Merrill J. Egorin, Gary L. Rosner et al. · Journal of Clinical Oncology · 2000 · 195 citations

Pharmacy, Oncology, Pharmacology +12